Amyloid burden assessed by three amyloid PET tracers in the elenbecestat MissionAD Phase 3 program: Neuroimaging / evaluating treatments

2020 
    • Correction
    • Source
    • Cite
    • Save
    0
    References
    0
    Citations
    NaN
    KQI
    []
    Baidu
    map